Latest news
Estrella Immunopharma Inc (ESLA) Stock News Today - TradingKeyTradingKey · Sat, 08 Aug 2026 12:31:44 GMTEstrella Immunopharma Inc (ESLA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 11:02:07 GMTPrice to book forward of Estrella Immunopharma, Inc. – NASDAQ:ESLAW - TradingViewTradingView · Wed, 05 Aug 2026 03:18:07 GMTEstrella Immunopharma Activates Oregon Health & Science University as Third Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 12:00:00 GMTEstrella Immunopharma (ESLA) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeatMarketBeat · Mon, 03 Aug 2026 07:00:00 GMTEstrella activates new site in Texas for STARLIGHT-1 Phase I/II trial - Clinical Trials ArenaClinical Trials Arena · Thu, 30 Jul 2026 11:05:47 GMTEstrella Immunopharma activates second clinical site for STARLIGHT-1 trial - TipRanksTipRanks · Wed, 29 Jul 2026 16:34:34 GMTEstrella Immunopharma Inc (ESLA) Balance Sheet - TradingKeyTradingKey · Mon, 27 Jul 2026 07:57:29 GMT